S&P 500 7,674.48 −1.07%
Nasdaq 26,157.61 −2.04%
S&P/TSX 35,943.02 −1.05%
Apple 345.71 +0.50%
Nvidia 213.46 −3.83%
Microsoft 526.19 −1.27%
Shopify 239.84 −2.08%
Royal Bank 282.81 −0.29%
CAD/USD 0.7131 +0.31%
LIVE · 12:05 ET
Market ClerkRecap
Thu Oct 22 · markets open6 signals today108 insider buys this week · $250.3MCIRO short report next: Oct 31The week ahead

ZTS

Zoetis Inc.
NYSE · HEALTH CARE · PHARMACEUTICAL PREPARATIONS
81.96
+2.34 +2.94%
USD · close Oct 22

A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up

MKT CAP $33.9BP/E 13.5DIV YIELD 2.55%FCF YIELD 6.84%REV TTM $9.5B +1.5%NET INCOME $2.6B +1.0%NET DEBT $8.1B52W 69.10 – 147.53SEC XBRL · TTM TO Invalid Date

Financials

SEC XBRL · 62 PERIODS · WHOLE USD

By quarter

PeriodRevenueYoYGross marginOperating incomeNet incomeYoYEPSOp. cash flowCapexFree cash flowFiled
Q2 2026 · Jun 30$2.5B−0.2%72.7%—$691M−4.8%1.65$655M$117M$538MAug 6
Q1 2026 · Mar 31$2.3B+2.9%71.7%—$601M−0.2%1.42$401M$110M$291MMay 7
Q4 2025 · Dec 31derived$2.4B+3.0%70.2%—$603M+3.8%1.37$893M$161M$732MFeb 12
Q3 2025 · Sep 30$2.4B+0.5%71.5%—$721M+5.7%1.63$891M$136M$755MNov 4
Q2 2025 · Jun 30$2.5B+4.8%73.2%—$726M+16.3%1.63$605M$146M$459MAug 6
Q1 2025 · Mar 31$2.2B+0.4%71.9%—$602M+0.5%1.34$515M$178M$337MMay 7
Q4 2024 · Dec 31derived$2.3B+4.7%69.5%—$581M+10.7%1.29$905M$216M$689MFeb 12
Q3 2024 · Sep 30$2.4B+11.0%70.6%—$682M+14.4%1.50$951M$167M$784MNov 4
Q2 2024 · Jun 30$2.4B—71.7%—$624M—1.37$502M$132M$370MAug 5
Q1 2024 · Mar 31$2.2B—70.6%—$599M—1.31$595M$140M$455MMay 6
Q4 2023 · Dec 31derived$2.2B—67.1%—$525M—1.14$897M$198M$699MFeb 12
Q3 2023 · Sep 30$2.2B—70.3%—$596M—1.29$724M$145M$579MNov 4

By fiscal year

YearRevenueGross marginOperating incomeNet incomeNet marginEPSOp. cash flowCapexFree cash flowBuybacksDividends paid
FY2025 · to Dec 31$9.5B71.8%—$2.7B28.2%6.02$2.9B$621M$2.3B$3.2B—
FY2024 · to Dec 31$9.3B70.6%—$2.5B26.9%5.47$3B$655M$2.3B$1.9B—
FY2023 · to Dec 31$8.5B70.0%—$2.3B27.4%5.07$2.4B$732M$1.6B$1.1B—
FY2022 · to Dec 31$8.1B69.6%—$2.1B26.2%4.49$1.9B$586M$1.3B$1.6B—
FY2021 · to Dec 31$7.8B70.4%—$2B26.2%4.27$2.2B$477M$1.7B$743M—
FY2020 · to Dec 31$6.7B69.2%—$1.6B24.5%3.42$2.1B$453M$1.7B$250M—

Every number comes from Zoetis Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.

Watch ZTS. Know when insiders buy.
One email the day a filing lands. Free.